UNSPSC 85592360: Supplement stomach with autologous tissue substitute, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement stomach with autologous tissue substitute, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DU677Z

UNSPSC 85592360 Supplement stomach with autologous tissue substitute, via natural or artificial opening is a Commodity code that shows no meaningful alignment with recent state and local procurement activity. The code nominal scope describes a surgical procedure involving tissue grafting; however, the six recent opportunities posted under this code—spanning occupational medical surveillance, independent medical evaluations for pension determinations, pharmacy benefit management, surgical center-of-excellence networks, temporary health professional staffing, and emergency care for detained youth—address healthcare administration, provider networks, and staffing services rather than surgical implant or tissue-substitute procurement. None of the solicitations tracked under this code name or request the specified surgical procedure or material.

The mismatch between the code's clinical taxonomy and the actual work being bought suggests either a systematic miscoding by issuing bodies or limited relevance of this particular code to state and local procurement patterns. The geographic spread of recent activity spans Arizona (City of Phoenix), California (City of Long Beach, County of Santa Clara), Washington (Washington State Department of Transportation), Florida (Collier County), and Texas (Harris County), but that distribution reflects the broad jurisdictions posting healthcare-related work rather than concentration in any single code's intended scope. Issuing bodies include county human resources divisions, health systems, pension boards, and transportation agencies—a wide mix of healthcare procurement actors. Without opportunities that directly solicit the tissue substitute procedure or related surgical material specified in the code, the code presents minimal business development relevance for vendors in that product line.